Cargando…

Evaluation of a Physiologically Based Pharmacokinetic (PBPK) Model for Inorganic Arsenic Exposure Using Data from Two Diverse Human Populations

BACKGROUND: Multiple epidemiological studies exist for some of the well-studied health endpoints associated with inorganic arsenic (iAs) exposure; however, results are usually expressed in terms of different exposure/dose metrics. Physiologically based pharmacokinetic (PBPK) models may be used to ob...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Masri, Hisham A., Hong, Tao, Henning, Cara, Mendez, William, Hudgens, Edward E., Thomas, David J., Lee, Janice S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Environmental Health Perspectives 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108830/ https://www.ncbi.nlm.nih.gov/pubmed/30024383 http://dx.doi.org/10.1289/EHP3096

Ejemplares similares

Erratum: “Evaluation of a Physiologically Based Pharmacokinetic (PBPK) Model for Inorganic Arsenic Exposure Using Data from Two Diverse Human Populations”
por: El-Masri, Hisham A., et al.
Publicado: (2018)

Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK
por: Wagner, C, et al.
Publicado: (2015)

Physiologically Based Pharmacokinetic (PBPK) Modeling of Metabolic Pathways of Bromochloromethane in Rats
por: Cuello, W. S., et al.
Publicado: (2012)

Current Approaches and Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials
por: Utembe, Wells, et al.
Publicado: (2020)

Physiologically based pharmacokinetic (PBPK) modeling and simulation in drug discovery and development
por: Shaik, Abdul Naveed, et al.
Publicado: (2019)

Physiologically-Based Pharmacokinetic (PBPK) Modeling Providing Insights into Fentanyl Pharmacokinetics in Adults and Pediatric Patients
por: Kovar, Lukas, et al.
Publicado: (2020)

Development of a Human Physiologically Based Pharmacokinetic (PBPK) Toolkit for Environmental Pollutants
por: Ruiz, Patricia, et al.
Publicado: (2011)

Physiologically Based Pharmacokinetic (PBPK) Modeling of Interstrain Variability in Trichloroethylene Metabolism in the Mouse
por: Chiu, Weihsueh A., et al.
Publicado: (2014)

Physiologically-Based Pharmacokinetic (PBPK) Modeling of Buprenorphine in Adults, Children and Preterm Neonates
por: Kovar, Lukas, et al.
Publicado: (2020)

Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Brain Levels of Drug in Rat
por: Sánchez-Dengra, Bárbara, et al.
Publicado: (2021)

Chronic dietary exposure to inorganic arsenic
por: Arcella, Davide, et al.
Publicado: (2021)

Evaluation of Plasma Arsenicals as Potential Biomarkers of Exposure to Inorganic Arsenic
por: Bommarito, Paige A., et al.
Publicado: (2019)

The Implications of Using a Physiologically Based Pharmacokinetic (PBPK) Model for Pesticide Risk Assessment
por: Lu, Chensheng, et al.
Publicado: (2010)

Physiologically-Based Pharmacokinetic (PBPK) Modeling and Simulations Principles, Methods, and Applications in the Pharmaceutical Industry
por: Rowland, M
Publicado: (2013)

Physiologically Based Pharmacokinetic (PBPK) Model for Biodistribution of Radiolabeled Peptides in Patients with Neuroendocrine Tumours
por: Gospavic, Radovan, et al.
Publicado: (2016)

Development of a physiologically based pharmacokinetic (PBPK) population model for Chinese elderly subjects
por: Cui, Cheng, et al.
Publicado: (2021)

A Physiologically Based Pharmacokinetic (PBPK) Modeling Framework for Mixtures of Dioxin-like Compounds
por: Liu, Rongrui, et al.
Publicado: (2022)

Report from the EMA workshop on qualification and reporting of physiologically based pharmacokinetic (PBPK) modeling and simulation
por: Zhao, P
Publicado: (2017)

Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry Perspective
por: Riedmaier, Arian Emami, et al.
Publicado: (2020)

The First Physiologically Based Pharmacokinetic (PBPK) Model for an Oral Vaccine Using Alpha-Tocopherol as an Adjuvant
por: Saldanha, Leonor, et al.
Publicado: (2023)

Pharmacokinetics of toxic chemicals in breast milk: use of PBPK models to predict infant exposure.
por: Clewell, Rebecca A, et al.
Publicado: (2002)

Exposure to Inorganic Arsenic in Rice in Brazil: A Human Health Risk Assessment
por: Toledo, Michele C., et al.
Publicado: (2022)

A biological indicator of inorganic arsenic exposure using the sum of urinary inorganic arsenic and monomethylarsonic acid concentrations
por: Hata, Akihisa, et al.
Publicado: (2016)

A comprehensive physiologically based pharmacokinetic (PBPK) model for nicotine in humans from using nicotine-containing products with different routes of exposure
por: Rostami, Ali A., et al.
Publicado: (2022)

Metabolism of inorganic arsenic in children with chronic high arsenic exposure in northern Argentina.
por: Concha, G, et al.
Publicado: (1998)

Biomarkers of Exposure: A Case Study with Inorganic Arsenic
por: Hughes, Michael F.
Publicado: (2006)

Inter‐ and Transgenerational Effects of Paternal Exposure to Inorganic Arsenic
por: Gong, Yingyun, et al.
Publicado: (2021)

Requirements to Establishing Confidence in Physiologically Based Pharmacokinetic (PBPK) Models and Overcoming Some of the Challenges to Meeting Them
por: Peters, Sheila Annie, et al.
Publicado: (2019)

Physiologically Based Pharmacokinetic (PBPK) Model of Gold Nanoparticle-Based Drug Delivery System for Stavudine Biodistribution
por: Zazo, Hinojal, et al.
Publicado: (2022)

Development of a Minimalistic Physiologically Based Pharmacokinetic (mPBPK) Model for the Preclinical Development of Spectinamide Antibiotics
por: Parmar, Keyur R., et al.
Publicado: (2023)

Arsenic Methyltransferase and Methylation of Inorganic Arsenic
por: Roy, Nirmal K., et al.
Publicado: (2020)

Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations
por: Krauss, Markus, et al.
Publicado: (2015)

Excretion of arsenic in urine as a function of exposure to arsenic in drinking water.
por: Calderon, R L, et al.
Publicado: (1999)

ATLAS mPBPK: A MATLAB‐Based Tool for Modeling and Simulation of Minimal Physiologically‐Based Pharmacokinetic Models
por: Mavroudis, Panteleimon D., et al.
Publicado: (2019)

Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan
por: Grzegorzewski, Jan, et al.
Publicado: (2022)

Impact of Water Regimes and Amendments on Inorganic Arsenic Exposure to Rice
por: Majumder, Supriya, et al.
Publicado: (2021)

Author Correction: A comprehensive physiologically based pharmacokinetic (PBPK) model for nicotine in humans from using nicotine-containing products with different routes of exposure
por: Rostami, Ali A., et al.
Publicado: (2022)

Prediction of pharmacokinetics and drug-drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach: A case study of caffeine and ciprofloxacin
por: Park, Min-Ho, et al.
Publicado: (2017)

Estimating Inorganic Arsenic Exposure from U.S. Rice and Total Water Intakes
por: Mantha, Madhavi, et al.
Publicado: (2017)

Prediction of Drug–Drug Interactions Between Opioids and Overdosed Benzodiazepines Using Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation
por: Ji, Beihong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_02fjhl1efmedmgjkd74dajnuii